Delivery Order SPE2DB24D2013-SPE2DB25FCJVA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90s, with a ceiling value of $50,074.67. This firm fixed-price delivery order, which is set to complete by September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $12,152.93 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and extending through December 2026. The award was...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a ceiling value of $21,238.14. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $53,873.78. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $3,919.62. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with a substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $7,829.28. This firm fixed price delivery order, with an ultimate completion date of September 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The contract was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $15,925.23 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The award was not...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $3,289.88 under firm fixed pricing. This contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award is non-set-aside and was competitively awarded, with the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Jardiance 10 mg tablets (90-count) at a ceiling value of $18,553.56 under a firm fixed-price contract. This non-set-aside award represents a continuation order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCJVADelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $61,893.35. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made on a non-set-aside, competitive basis and reflects the company's established role as a primary pharmaceutical distributor for federal military and veteran healthcare systems. Performance will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio focused on supplying a comprehensive range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Jardiance delivery order is consistent with the company's demonstrated capability in fulfilling federal medical procurement requirements, including specialty medications across multiple therapeutic domains. The underlying SPE2DX vehicle is designed to provide global pharmaceutical support for military healthcare programs, positioning AmerisourceBergen as a critical vendor within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.9k | 8/5/25 |